Go Pro
LON:VAL

ValiRx Final Earnings Report

ValiRx logo
GBX 0.17 +0.00 (+1.21%)
As of 11:37 AM Eastern

ValiRx EPS Results

Actual EPS
-GBX 0.54
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ValiRx Revenue Results

Actual Revenue
$0.03 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ValiRx Announcement Details

Quarter
Final
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

ValiRx Earnings Headlines

A Secret Plan to End Trump in November?
A White House insider with close ties to the Trump family is speaking out about what he calls the biggest political betrayal in American history. He warns this midterm election development could have a significant impact on investors' wealth in the coming months and years.tc pixel
See More ValiRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ValiRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ValiRx and other key companies, straight to your email.

About ValiRx

ValiRx (LON:VAL) accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

View ValiRx Profile